SEC Form 4 · accession 0001140361-15-005640
Raptor Pharmaceutical Corp · RPTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas E Daley
Officer — Chief Business Officer
Period of report
Feb 9, 2015
Accepted (ET)
Feb 11, 2015 · 8:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070698
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 9, 2015 | A | 11,500 | $0.00 | A | 74,719 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options (right to buy)F2 | $9.36 | Feb 9, 2015 | A | 43,100 | A | — | Feb 9, 2025 | Common Stock | 43,100 | 43,100 | D |
Explanation of responses
- F1Restricted Stock Units ("RSUs"). The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU upon the vesting thereof.
- F2Stock options vest 6/48ths on the six month anniversary of grant date and 1/48th per month thereafter.